Yale scientists identify genetic form of hypertension in pregnant women

July 06, 2000

A Yale research team led by Richard P. Lifton, M.D., professor of genetics, medicine, and molecular biophysics and biochemistry, has identified the molecular cause of an inherited form of hypertension in pregnant women.

"We investigated a family with unusually severe hypertension and David Geller, one of our team members, discovered a mutation in the mineralocorticoid receptor gene in this family," said Lifton. "We demonstrated that this mutation causes a new form of hypertension that is exacerbated by pregnancy."

Hypertension that develops or worsens with pregnancy complicates about six percent of all pregnancies and is a major public health problem, contributing to pre-eclampsia, a hypertensive disorder of pregnancy that increases both fetal and maternal morbidity and mortality. The causes are largely unknown.

A steroid called aldosterone normally activates the mineralocorticoid receptor, Lifton said, increasing salt balance and raising blood pressure. When women with this mutation become pregnant, the 100-fold increase in progesterone b -- a normal hormone of pregnancy -- can also activate this receptor, causing increased salt balance and marked worsening of hypertension.

"Our findings demonstrate that a normal hormone of pregnancy can have abnormal effects that can cause hypertension to worsen and raises the possibility that more common forms of pregnancy-related hypertension may be attributable to similar mechanisms," Lifton said.

The findings, he said, will motivate careful examination of the possibility that progesterone is acting to promote increased salt balance in other forms of pregnancy-related hypertension.

"These findings may lead to clinical trials of salt restriction in selected groups of women whose blood pressure rises with pregnancy," said Lifton.
Lifton's team included David S. Geller, first author on the study, Anita Farhl, Nikki Pinkerton, Michael Fradley, Michael Moritz, Adrian Spitzer, Gretchen Meinke, Francis T.F. Tsal and Paul B. Sigler, M.D.

Yale University

Related Hypertension Articles from Brightsurf:

Risk of target organ damage in patients with masked hypertension versus sustained hypertension
In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.1261, Yue Wu, Guoyue Zhang, Rong Hu and Jianlin Du from The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China consider the risk of target organ damage in patients with masked hypertension versus sustained hypertension.

Overactive enzyme causes hereditary hypertension
After more than 40 years, several teams at the MDC and ECRC have now made a breakthrough discovery with the help of two animal models: they have proven that an altered gene encoding the enzyme PDE3A causes an inherited form of high blood pressure.

Diagnosing hypertension in children
Study results call into question the utility of testing blood pressure load--the proportion of elevated blood pressure readings detected over 24 hours--for diagnosing hypertension in children.

When the best treatment for hypertension is to wait
A new study concluded that a physician's decision not to intensify hypertension treatment is often a contextually appropriate choice.

Treatment of hypertension induced albuminuria
Patients with albuminuria will usually need more than one drug to achieve blood pressure control, particularly if the aim is also to reduce albuminuria.

Diagnosing and treating resistant hypertension
Resistant blood pressure affects 12 percent to 15 percent of people currently being treated for high blood pressure.

Dementia can be caused by hypertension
A new study in Cardiovascular Research indicates that patients with high blood pressure are at a higher risk of developing dementia.

Hormone imbalance causes treatment-resistant hypertension
British researchers have discovered a hormone imbalance that explains why it is very difficult to control blood pressure in around 10 per cent of hypertension patients.

Breastfeeding reduces hypertension risk
A study published in the American Journal of Hypertension indicates that women who breastfeed more children, and for longer periods of time, are less likely to suffer from hypertension after they reach menopause.

Lung cancer triggers pulmonary hypertension
Nearly half of all advanced-stage lung cancer patients develop arterial pulmonary hypertension.

Read More: Hypertension News and Hypertension Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.